Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with glioblastoma (a type of brain tumour), either for the first time or as a recurrence
- People who have already received standard treatment, which includes surgery and a combination of chemotherapy (using a drug called temozolomide) and radiation therapy
- People for whom enough tumour tissue was collected during surgery to be used for a special lab culture called an organoid
Who may not be able to join:
- People who did not receive the combined chemotherapy and radiation therapy after their surgery
- People for whom an MRI scan was not completed after the combined chemotherapy and radiation therapy
- People who do not wish to participate in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kyung Hwan Kim, MD, PhD, Department of Neurosurgery, Chungnam National University Hospital
Phone: 82-42-280-7367
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
progression-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.